APA-referens (7:e uppl.)

Li, L., Xu, N., He, Y., Tang, M., Yang, B., Du, J., . . . Lee, S. M. (2025). Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammation. Neurotherapeutics, 22(2), . https://doi.org/10.1016/j.neurot.2024.e00479

Chicago-referens (17:e uppl.)

Li, Lin, et al. "Dehydroervatamine as a Promising Novel TREM2 Agonist, Attenuates Neuroinflammation." Neurotherapeutics 22, no. 2 (2025). https://doi.org/10.1016/j.neurot.2024.e00479.

MLA-referens (9:e uppl.)

Li, Lin, et al. "Dehydroervatamine as a Promising Novel TREM2 Agonist, Attenuates Neuroinflammation." Neurotherapeutics, vol. 22, no. 2, 2025, https://doi.org/10.1016/j.neurot.2024.e00479.